alexa Bupropion Use for Adjuvant Analgesia in a Patient with

Fibromyalgia: Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Bupropion Use for Adjuvant Analgesia in a Patient with Fibromyalgia: A Case Report

Adam Gummersheimer1, Tabetha Todd1 and Christopher M. Herndon2*

1Southern Illinois University Edwardsville, 200 University Park Drive, Box 2000, Edwardsville, USA

2Associate Professor, School of Pharmacy, Advanced Practice Pharmacist, Scott Air Force Base, Southern Illinois University Edwardsville, 200 University Park Drive, Box 2000, Edwardsville, USA

*Corresponding Author:
Christopher M. Herndon
Associate Professor, School of Pharmacy
Advanced Practice Pharmacist, Scott Air Force Base
Southern Illinois University Edwardsville
200 University Park Drive, Box 2000, Edwardsville, USA
Tel: 618-420-9886
E-mail: [email protected]

Received date: January 08, 2016 Accepted date: February 28, 2016 Published date: March 02, 2016

Citation: Gummersheimer A, Todd T and Herndon CM (2016) Bupropion Use for Adjuvant Analgesia in a Patient with Fibromyalgia: A Case Report. Fibrom Open Access 1: 106. doi:10.4172/foa.1000106

Copyright: © 2016 Gummersheimer A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Fibromyalgia is a chronic syndrome characterized by widespread pain, fatigue, gastrointestinal disturbances, neurocognitive dulling, and insomnia. Currently, three medications are approved for fibromyalgia by the United States Food and Drug Administration (FDA): pregabalin, duloxetine, and milnacipran. This case study reviews the use of bupropion as a potential co-analgesic in patients with refractory fibromyalgia. Previous studies have assessed the use of dopamine agonists in the treatment of fibromyalgia with both ropinirole and pramipexole exhibiting efficacy. Bupropion, an atypical antidepressant with noradrenergic and dopaminergic modulatory effects, may theoretically provide similar efficacy in patients with fibromyalgia syndrome.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords